SEC Form 4 · accession 0002098678-26-000004
Pulmonx Corp · LUNG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Srikanth Radhakrishnan
Officer — Chief Science & Techn. Officer
Period of report
Sep 1, 2026
Accepted (ET)
Sep 3, 2026 · 6:21 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001127537
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 1, 2026 | S | 2,643 | $2.26 | D | 328,596 | D | |
| Common Stock | Sep 1, 2026 | S | 2,121 | $2.26 | D | 326,475 | D | |
| Common Stock | Sep 1, 2026 | S | 3,618 | $2.26 | D | 322,857 | D | |
| Common Stock | Sep 1, 2026 | S | 5,863 | $2.26 | D | 316,994 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2023.
- F2These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024.
- F3These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 3, 2025.
- F4These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 2, 2026.